Comparison

LRRK2-IN-2 European Partner

Item no. HY-145317-100mg
Manufacturer MedChem Express
CASRN 2641059-19-8
Amount 100 mg
Category
Type Chemicals
Specific against other
Citations [1]Keylor MH, et, al. Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors. J Med Chem. 2022 Jan 13;65(1):838-856.
Smiles FC1([C@@H](N2C(Cl)=C(C=N2)NC3=NC4=C(C=C(C([C@H]5[C@@H](CN([C@H]6[C@H](COC6)O)CC5)F)=C4)Cl)C=N3)C1)F
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
LRRK2-IN-2 (compoubd 22) is a potent, selective, orally active and brain-penetrant inhibitor LRRK2, with IC50 of <0.6 nM. LRRK2-IN-2 can be used for the research of Parkinson's disease[1].
Shipping
Room temperature
Manufacturers Applications
Neuroscience-Neurodegeneration
MolecularWeight
543.37
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease
Solubility
10 mM in DMSO
Pathway
Autophagy
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close